BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30593134)

  • 1. Ischemia reperfusion injury in kidney transplantation: A case report.
    Philipponnet C; Aniort J; Garrouste C; Kemeny JL; Heng AE
    Medicine (Baltimore); 2018 Dec; 97(52):e13650. PubMed ID: 30593134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.
    Yang B; Dieudé M; Hamelin K; Hénault-Rondeau M; Patey N; Turgeon J; Lan S; Pomerleau L; Quesnel M; Peng J; Tremblay J; Shi Y; Chan JS; Hébert MJ; Cardinal H
    Am J Transplant; 2016 Dec; 16(12):3416-3429. PubMed ID: 27172087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation.
    Ponticelli C
    Nephrol Dial Transplant; 2014 Jun; 29(6):1134-40. PubMed ID: 24335382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation.
    Wewers TM; Mayer AB; Pfleiderer A; Beul K; Schmidt R; Heitplatz B; Van Marck V; Nolte I; Pavenstädt H; Reuter S; Brand M; Di Marco GS
    Kidney Int; 2019 May; 95(5):1091-1102. PubMed ID: 30824181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function.
    Castellano G; Intini A; Stasi A; Divella C; Gigante M; Pontrelli P; Franzin R; Accetturo M; Zito A; Fiorentino M; Montinaro V; Lucarelli G; Ditonno P; Battaglia M; Crovace A; Staffieri F; Oortwijn B; van Amersfoort E; Pertosa G; Grandaliano G; Gesualdo L
    Am J Transplant; 2016 Jan; 16(1):325-33. PubMed ID: 26280899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.
    Huang E; Vo A; Choi J; Ammerman N; Lim K; Sethi S; Kim I; Kumar S; Najjar R; Peng A; Jordan SC
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):109-116. PubMed ID: 31843975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of arteriolar hyalinosis in post-reperfusion biopsies represents an additional risk to ischaemic injury in renal transplant.
    Matos AC; Câmara NO; REQUIãO-Moura LR; Tonato EJ; Filiponi TC; Souza-DURãO M; Malheiros DM; Fregonesi M; Borrelli M; Pacheco-Silva A
    Nephrology (Carlton); 2016 Nov; 21(11):923-929. PubMed ID: 26661292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peri-operative hyperglycemia is associated with delayed graft function in deceased donor renal transplantation.
    Parekh J; Roll GR; Feng S; Niemann CU; Hirose R
    Clin Transplant; 2013; 27(4):E424-30. PubMed ID: 23808826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of renal ischemia reperfusion injury subtypes and predictive strategies for delayed graft function and graft survival based on neutrophil extracellular trap-related genes.
    Wu J; Zhang F; Zheng X; Zhang J; Cao P; Sun Z; Wang W
    Front Immunol; 2022; 13():1047367. PubMed ID: 36532016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial.
    Sun Q; Hong L; Huang Z; Na N; Hua X; Peng Y; Zhao M; Cao R; Sun Q
    Trials; 2017 Nov; 18(1):545. PubMed ID: 29145879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and consequences of delayed graft function.
    Ounissi M; Cherif M; Abdallah TB; Bacha M; Hedri H; Abderrahim E; Goucha R; Kheder A; Slama RB; Derouiche A; Chebil M; Bardi R; Sfar I; Gorgi Y
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):243-6. PubMed ID: 23538345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
    Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
    Front Immunol; 2020; 11():1886. PubMed ID: 32983110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of graft loss 5 years after kidney transplantation is increased if cold ischemia time exceeds 14 hours.
    Hansson J; Mjörnstedt L; Lindnér P
    Clin Transplant; 2018 Sep; 32(9):e13377. PubMed ID: 30098052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deceased Donor Renal Transplantation: 6 Year Experience from a Tertiary Care Center in North India.
    Bhardwaj S; Agarwal D; Malhotra V; Gupta R; Singh S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.
    Kassimatis T; Qasem A; Douiri A; Ryan EG; Rebollo-Mesa I; Nichols LL; Greenlaw R; Olsburgh J; Smith RA; Sacks SH; Drage M
    Trials; 2017 Jun; 18(1):255. PubMed ID: 28587616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early kinetics of donor-derived cell-free DNA after transplantation predicts renal graft recovery and long-term function.
    Cucchiari D; Cuadrado-Payan E; Gonzalez-Roca E; Revuelta I; Argudo M; Ramirez-Bajo MJ; Ventura-Aguiar P; Rovira J; Bañon-Maneus E; Montagud-Marrahi E; Rodriguez-Espinosa D; Cacho J; Arana C; Torregrosa V; Esforzado N; Cofàn F; Oppenheimer F; Musquera M; Peri L; Casas S; Dholakia S; Palou E; Campistol JM; Bayés B; Puig JA; Diekmann F
    Nephrol Dial Transplant; 2023 Dec; 39(1):114-121. PubMed ID: 37715343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed graft function in kidney transplantation.
    Bahl D; Haddad Z; Datoo A; Qazi YA
    Curr Opin Organ Transplant; 2019 Feb; 24(1):82-86. PubMed ID: 30540574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed graft function and its management in children.
    Grenda R
    Pediatr Nephrol; 2017 Jul; 32(7):1157-1167. PubMed ID: 27778091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.